[1] Sundahl N, Duprez F, Ost P, et al.  Effects of radiation on the metastatic process[J]. Mol Med, 2018, 24(1): 16-.   doi: 10.1186/s10020-018-0015-8
[2] Candido J, Hagemann T.  Cancer-related inflammation[J]. J Clin Immunol, 2013, 33(Suppl 1): S79-84.   doi: 10.1007/s10875-012-9847-0
[3] Vilalta M, Rafat M, Graves EE.  Effects of radiation on metastasis and tumor cell migration[J]. Cell Mol Life Sci, 2016, 73(16): 2999-3007.   doi: 10.1007/s00018-016-2210-5
[4]

Kim ES, Choi YE, Hwang SJ, et al. IL-4, a direct target of miR-340/429, is involved in radiation-induced aggressive tumor behavior in human carcinoma cells[J/OL]. Oncotarget, 2016, 7(52): 86836−86856[2019-07-11]. http://www.oncotarget.com/article/13561/text. DOI: 10.18632/oncotarget.13561.
[5]

Zang CB, Liu XJ, Li B, et al. IL-6/STAT3/TWIST inhibition reverses ionizing radiation-induced EMT and radioresistance in esophageal squamous carcinoma[J/OL]. Oncotarget, 2017, 8(7): 11228−11238[2019-07-11]. http://www.oncotarget.com/article/14495/text. DOI: 10.18632/oncotarget.14495.
[6] Moncharmont C, Levy A, Guy JB, et al.  Radiation-enhanced cell migration/invasion process: a review[J]. Crit Rev Oncol Hematol, 2014, 92(2): 133-142.   doi: 10.1016/j.critrevonc.2014.05.006
[7] Nambiar DK, Rajamani P, Singh RP.  Silibinin attenuates ionizing radiation-induced pro-angiogenic response and EMT in prostate cancer cells[J]. Biochem Biophys Res Commun, 2015, 456(1): 262-268.   doi: 10.1016/j.bbrc.2014.11.069
[8] Jin H, Ko YS, Kim HJ.  P2Y2R-mediated inflammasome activation is involved in tumor progression in breast cancer cells and in radiotherapy-resistant breast cancer[J]. Int J Oncol, 2018, 53(5): 1953-1966.   doi: 10.3892/ijo.2018.4552
[9] Chen XL, Zhang LR, Jiang YJ, et al.  Radiotherapy-induced cell death activates paracrine HMGB1-TLR2 signaling and accelerates pancreatic carcinoma metastasis[J]. J Exp Clin Cancer Res, 2018, 37(1): 77-.   doi: 10.1186/s13046-018-0726-2
[10]

Feys L, Descamps B, Vanhove C, et al. Radiation-induced lung damage promotes breast cancer lung-metastasis through CXCR4 signaling[J/OL]. Oncotarget, 2015, 6(29): 26615−26632[2019-07-11]. http://www.oncotarget.com/article/5666/text. DOI: 10.18632/oncotarget.5666.
[11]

Lee SY, Jeong EK, Ju MK, et al. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation[J/OL]. Mol Cancer, 2017, 16(1): 10[2019-07-11]. https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-016-0577-4. DOI: 10.1186/s12943-016-0577-4.
[12] Ohuchida K, Mizumoto K, Murakami M, et al.  Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions[J]. Cancer Res, 2004, 64(9): 3215-3222.   doi: 10.1158/0008-5472.can-03-2464
[13] Rüegg C, Monnier Y, Kuonen F, et al.  Radiation-induced modifications of the tumor microenvironment promote metastasis[J]. Bull Cancer, 2011, 98(6): 47-57.   doi: 10.1684/bdc.2011.1372
[14]

Teng F, Tian WY, Wang YM, et al. Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis[J/OL]. J Hematol Oncol, 2016, 9: 8[2019-07-11]. https://jhoonline.biomedcentral.com/articles/10.1186/s13045-015-0231-4. DOI: 10.1186/s13045-015-0231-4.
[15] Ji XQ, Zhu XX, Lu XG.  Effect of cancer-associated fibroblasts on radiosensitivity of cancer cells[J]. Future Oncol, 2017, 13(17): 1537-1550.   doi: 10.2217/fon-2017-0054
[16]

Luo GJ, He YD, Yu XJ. Bone marrow adipocyte: an intimate partner with tumor cells in bone metastasis[J/OL]. Front Endocrinol (Lausanne), 2018, 9: 339[2019-07-11]. https://www.frontiersin.org/articles/10.3389/fendo.2018.00339/full. DOI: 10.3389/fendo.2018.00339.
[17]

Gu Q, He Y, Ji JF, et al. Hypoxia-inducible factor 1α (HIF-1α) and reactive oxygen species (ROS) mediates radiation-induced invasiveness through the SDF-1α/CXCR4 pathway in non-small cell lung carcinoma cells[J/OL]. Oncotarget, 2015, 6(13): 10893−10907[2019-07-11]. http://www.oncotarget.com/article/3535/text. DOI: 10.18632/oncotarget.3535.
[18] Kuonen F, Secondini C, Rüegg C.  Molecular pathways: emerging pathways mediating growth, invasion, and metastasis of tumors progressing in an irradiated microenvironment[J]. Clin Cancer Res, 2012, 18(19): 5196-5202.   doi: 10.1158/1078-0432.CCR-11-1758
[19]

Arnold KM, Flynn NJ, Raben A, et al. The impact of radiation on the tumor microenvironment: effect of dose and fractionation schedules[J/OL]. Cancer Growth Metastasis, 2018, 11: 1−17[2019-07-11]. https://journals.sagepub.com/doi/pdf/10.1177/1179064418761639. DOI: 10.1177/1179064418761639.
[20] Purdy JA.  Dose to normal tissues outside the radiation therapy patient's treated volume: a review of different radiation therapy techniques[J]. Health Phys, 2008, 95(5): 666-676.   doi: 10.1097/01.HP.0000326342.47348.06
[21] Rofstad EK, Mathiesen B, Galappathi K.  Increased metastatic dissemination in human melanoma xenografts after subcurative radiation treatment: radiation-induced increase in fraction of hypoxic cells and hypoxia-induced up-regulation of urokinase-type plasminogen activator receptor[J]. Cancer Res, 2004, 64(1): 13-18.   doi: 10.1158/0008-5472.can-03-2658
[22] Desgrosellier JS, Cheresh DA.  Integrins in cancer: biological implications and therapeutic opportunities[J]. Nat Rev Cancer, 2010, 10(1): 9-22.   doi: 10.1038/nrc2748
[23] Rajput S, Kumar BN, Banik P, et al.  Thymoquinone restores radiation-induced TGF-β expression and abrogates EMT in chemoradiotherapy of breast cancer cells[J]. J Cell Physiol, 2015, 230(3): 620-629.   doi: 10.1002/jcp.24780
[24]

Mutschelknaus L, Azimzadeh O, Heider T, et al. Radiation alters the cargo of exosomes released from squamous head and neck cancer cells to promote migration of recipient cells[J/OL]. Sci Rep, 2017, 7(1): 12423[2019-7-11]. http://www.nature.com/articles/s41598-017-12403-6. DOI: 10.1038/s41598-017-12403-6.
[25]

Arscott WT, Tandle AT, Zhao SP, et al. Ionizing radiation and glioblastoma exosomes: implications in tumor biology and cell migration[J/OL]. Transl Oncol, 2013, 6(6): 638−648[2019-07-11]. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890698. DOI: 10.1593/tlo.13640.